We are live on ! Find out more
CLYM

Climb Bio
CLYM

68 hedge funds and large institutions have $89.7M invested in Climb Bio in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more capital invested

Capital invested by funds: $61.9M → $89.7M (+$27.8M)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1% less funds holding

Funds holding: 69 → 68 (-1)

7.96% less ownership

Funds ownership: 73.83% → 65.87% (-8%)

65% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 34

Holders
68
Holders Change
-1
Holders Change %
-1.45%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
12
Reduced
34
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$418K
2
Marshall Wace
Marshall Wace
United Kingdom
+$359K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$149K
4
LPL Financial
LPL Financial
California
+$113K
5
BCM
Bluefin Capital Management
New York
+$111K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$3.63M
2
Citigroup
Citigroup
New York
-$2.38M
3
DP
Diadema Partners
New Jersey
-$1.05M
4
DTC
Deep Track Capital
Connecticut
-$985K
5
SC
Shay Capital
New York
-$492K
Name Holding Trade Value Shares
Change 		Change in
Stake
CUAMC
51
China Universal Asset Management Company
China
$23.9K -$3.15K -1,694 -12%
PAS
52
Point72 Asia (Singapore)
Singapore
$22K -$5.82K -3,133 -22%
CPIG
53
Chicago Partners Investment Group
Illinois
$21.5K -$4.66K -2,510 -20%
Fidelity Investments
54
Fidelity Investments
Massachusetts
$14.4K -$900 -485 -6%
Bank of America
55
Bank of America
North Carolina
$11.6K -$3.48K -1,874 -25%
Federated Hermes
56
Federated Hermes
Pennsylvania
$8.88K +$8.21K +4,420 New
Mirae Asset Global Investments
57
Mirae Asset Global Investments
South Korea
$5.27K +$19 +10 +0.4%
HI
58
Harbour Investments
Wisconsin
$4.02K +$3.71K +2,000 New
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$3.73K -$10.8K -5,815 -76%
GFM
60
GF Fund Management
China
$2.93K -$293 -158 -10%
Nisa Investment Advisors
61
Nisa Investment Advisors
Missouri
$1.15K – – –
Royal Bank of Canada
62
Royal Bank of Canada
Ontario, Canada
$1K -$4.01K -2,161 -76%
EWA
63
EverSource Wealth Advisors
Alabama
$450 +$321 +173 +339%
AAP
64
Arax Advisory Partners
Colorado
$106 +$98 +53 New
ASN
65
Advisory Services Network
Georgia
$64 +$59 +32 New
SS
66
SBI Securities
Japan
$26 +$2 +1 +8%
Deutsche Bank
67
Deutsche Bank
Germany
$2 -$23K -12,381 -100%
Citadel Advisors
68
Citadel Advisors
Florida
– -$172K -138,392 Closed
YIH
69
Y-Intercept (HK)
Hong Kong
– -$159K -127,952 Closed
SCM
70
Stonepine Capital Management
Oregon
– -$144K -116,147 Closed
AQR Capital Management
71
AQR Capital Management
Connecticut
– -$35.8K -28,890 Closed
JG
72
Jain Global
New York
– -$31.9K -25,693 Closed
HF
73
HRT Financial
New York
– -$22K -18,529 Closed
SG Americas Securities
74
SG Americas Securities
New York
– -$17K -13,818 Closed
Carson Wealth (CWM LLC)
75
Carson Wealth (CWM LLC)
Nebraska
– -$4.24K -2,286 -96%
1 2
3
4

CLYM Hedge Fund Activity: Q3 2025 in Review

68 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q3 2025, worth a combined $89.7M — up 45% from $61.9M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CLYM and 12 opened new positions — a net loss of 1 holder — while 34 trimmed existing stakes and 12 added.

The largest buyer was Sphera Funds Management, adding an estimated $418K. The largest seller was Cantor Fitzgerald, cutting an estimated $3.63M.

  • 68 institutional investors held Climb Bio (CLYM) as of Q3 2025, down from 69 in Q2 2025.
  • Funds reported $89.7M of Climb Bio stock for Q3 2025, up 45% quarter-over-quarter.
  • 12 funds opened new Climb Bio positions in Q3 2025 and 13 closed out, a net change of -1 holder.
  • The largest Climb Bio buyer in Q3 2025 was Sphera Funds Management, an estimated $418K added.
  • The largest Climb Bio seller in Q3 2025 was Cantor Fitzgerald, an estimated $3.63M sold.

Based on aggregated 13F filings for Q3 2025.